ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1,3,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
3,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
4,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
5,1,Candida sepsis,Candida infections,Fungal infectious disorders,Infec,Y
5,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5,3,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
5,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
7,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
7,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7,5,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
8,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
9,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
10,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
10,4,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
11,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
12,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
13,1,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
14,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
14,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
16,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
16,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
16,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
17,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
19,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
20,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
21,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
21,2,Systemic candida,Candida infections,Fungal infectious disorders,Infec,N
22,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
22,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
23,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
23,2,Optic nerve disorder,Visual pathway disorders,Vision disorders,Eye,N
24,1,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,Y
25,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
25,2,Hepatosplenic candidiasis,Candida infections,Fungal infectious disorders,Infec,N
25,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
26,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
27,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
28,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
29,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
29,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
29,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
29,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
29,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
30,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
30,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
31,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
33,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
33,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
34,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
35,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
35,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
36,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
36,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
36,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
36,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
36,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
36,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
37,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
38,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
38,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
38,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
39,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
39,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
40,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
40,2,Systemic inflammatory response syndrome,Inflammations,General system disorders NEC,Genrl,N
41,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
42,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
43,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
43,2,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
43,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
43,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
43,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
44,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
44,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
45,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
46,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
46,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
46,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
46,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
46,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
46,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
46,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
46,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
47,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
47,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
48,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
49,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
49,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,Y
50,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
50,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
51,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
51,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
51,4,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
51,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
52,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
52,2,Chronic granulomatous disease,Immune system abnormalities congenital,Immune system disorders congenital,Cong,Y
52,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
52,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
53,1,Chronic granulomatous disease,Immune system abnormalities congenital,Immune system disorders congenital,Cong,N
53,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
53,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
53,4,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
53,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
54,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
54,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
54,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
54,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
54,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
55,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
56,1,Dilatation intrahepatic duct acquired,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
56,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
56,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
57,1,Dacryocanaliculitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
57,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,3,Eye abscess,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
57,4,Keratitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
57,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
58,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
58,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
59,1,Candida pneumonia,Candida infections,Fungal infectious disorders,Infec,Y
59,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
60,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
61,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
61,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
61,3,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
62,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
63,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
64,1,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
64,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
65,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
66,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
67,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
68,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
69,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
69,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
70,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
70,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
70,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
70,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
71,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
71,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
72,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
72,2,Parenteral nutrition,Dietary and nutritional therapies,Therapeutic procedures and supportive care NEC,Surg,N
72,3,Vascular catheterisation,Vascular therapeutic procedures NEC,Vascular therapeutic procedures,Surg,N
73,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
73,2,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
74,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
75,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
76,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
77,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
77,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
78,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
79,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
80,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
80,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
80,3,Monocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
80,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
80,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
80,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
81,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
82,1,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
82,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
83,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
84,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
84,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
84,3,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
85,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
85,2,Product preparation issue,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
86,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
86,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
87,1,Nikolsky's sign,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
87,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
88,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
89,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
89,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
90,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
90,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
91,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
92,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
92,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
92,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
92,4,Myoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
93,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
93,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
93,3,Neuropsychological symptoms,Mental disorders due to a general medical condition NEC,Psychiatric disorders NEC,Psych,N
93,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
94,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
94,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
94,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
94,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
94,5,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
94,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
94,7,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
94,8,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
95,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
95,2,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
95,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
95,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
95,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
95,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
95,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
95,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
95,9,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
95,10,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
95,11,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
95,12,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
96,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
97,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
97,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
98,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
99,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
100,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
100,2,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
100,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
100,5,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
100,6,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
100,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
100,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
101,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
101,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
101,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
102,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
102,3,Urinary tract infection fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
103,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
103,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,3,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
104,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
104,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,3,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
105,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
106,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
107,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
108,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
109,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
110,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
111,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
112,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
113,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
114,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
114,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
115,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
115,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
116,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
116,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
117,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
117,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
118,1,Abscess fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
118,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
118,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
118,4,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
118,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
118,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
118,7,Iliac artery disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
118,8,Infective aneurysm,Vascular infections,Infections - pathogen unspecified,Infec,N
118,9,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
118,10,Pneumonia acinetobacter,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
118,11,Renal artery perforation,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
118,12,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
119,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
119,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
119,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,4,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
119,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
119,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
119,7,Iliac artery disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
119,8,Infective aneurysm,Vascular infections,Infections - pathogen unspecified,Infec,N
119,9,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
119,10,Pneumonia acinetobacter,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
119,11,Renal artery perforation,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
119,12,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
120,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
121,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
122,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
123,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
123,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
123,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
124,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
124,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
124,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
124,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
124,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
125,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
